Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY – Get Free Report) gapped up prior to trading on Friday . The stock had previously closed at $70.74, but opened at $73.64. Sandoz Group shares last traded at $71.9995, with a volume of 969 shares traded.
Analyst Ratings Changes
SDZNY has been the topic of a number of research analyst reports. Jefferies Financial Group cut Sandoz Group from a “strong-buy” rating to a “hold” rating in a report on Friday, August 8th. Barclays upgraded Sandoz Group to a “strong-buy” rating in a research note on Monday, October 13th. One equities research analyst has rated the stock with a Strong Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy”.
Get Our Latest Stock Report on Sandoz Group
Sandoz Group Stock Up 1.4%
Sandoz Group Company Profile
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Further Reading
- Five stocks we like better than Sandoz Group
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Will Crypto Miners Pivot to AI? Latest on 3 Key Players
- 5 discounted opportunities for dividend growth investors
- Salesforce Stock Is Coiled Like a Spring and Ready to Rebound
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Marvell’s Rally Extends: Data Centers and AMZN Chips Boost Shares
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
